Literature DB >> 28490571

Evaluating a CLL susceptibility variant in ITGB2 in families with multiple subtypes of hematological malignancies.

Nicholas B Blackburn1,2, James R Marthick2, Annette Banks2, Jac C Charlesworth2, Katherine A Marsden3, Ray M Lowenthal2, John Blangero1, Joanne L Dickinson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28490571      PMCID： PMC5813724          DOI： 10.1182/blood-2017-03-774232

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Hematologically important mutations: leukocyte adhesion deficiency (first update).

Authors:  Edith van de Vijver; Anne Maddalena; Özden Sanal; Steven M Holland; Gulbu Uzel; Manisha Madkaikar; Martin de Boer; Karin van Leeuwen; M Yavuz Köker; Nima Parvaneh; Alain Fischer; S K Alex Law; Nigel Klein; F Ilhan Tezcan; Ekrem Unal; Turkan Patiroglu; Bernd H Belohradsky; Klaus Schwartz; Raz Somech; Taco W Kuijpers; Dirk Roos
Journal:  Blood Cells Mol Dis       Date:  2011-11-30       Impact factor: 3.039

2.  Evidence for a common genetic aetiology in high-risk families with multiple haematological malignancy subtypes.

Authors:  Elizabeth M Tegg; Russell J Thomson; Jim Stankovich; Annette Banks; Ceri Flowers; Rebekah McWhirter; Jean Panton; Anne Piaszczyk; Melanie Bahlo; Katherine A Marsden; Ray M Lowenthal; Simon J Foote; Joanne L Dickinson
Journal:  Br J Haematol       Date:  2010-06-15       Impact factor: 6.998

3.  Multipoint quantitative-trait linkage analysis in general pedigrees.

Authors:  L Almasy; J Blangero
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

4.  Whole exome sequencing in families with CLL detects a variant in Integrin β 2 associated with disease susceptibility.

Authors:  Lynn R Goldin; Mary L McMaster; Melissa Rotunno; Sarah E M Herman; Kristine Jones; Bin Zhu; Joseph Boland; Laurie Burdett; Belynda Hicks; Sarangan Ravichandran; Brian T Luke; Meredith Yeager; Laura Fontaine; Alisa M Goldstein; Stephen J Chanock; Margaret A Tucker; Adrian Wiestner; Gerald Marti; Neil E Caporaso
Journal:  Blood       Date:  2016-09-14       Impact factor: 22.113

Review 5.  Discussing and managing hematologic germ line variants.

Authors:  Wendy Kohlmann; Joshua D Schiffman
Journal:  Blood       Date:  2016-11-24       Impact factor: 22.113

6.  Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene.

Authors:  Melissa Rotunno; Mary L McMaster; Joseph Boland; Sara Bass; Xijun Zhang; Laurie Burdett; Belynda Hicks; Sarangan Ravichandran; Brian T Luke; Meredith Yeager; Laura Fontaine; Paula L Hyland; Alisa M Goldstein; Stephen J Chanock; Neil E Caporaso; Margaret A Tucker; Lynn R Goldin
Journal:  Haematologica       Date:  2016-06-13       Impact factor: 9.941

Review 7.  The Familial Tasmanian Haematological Malignancies Study (FaTHMS): its origins, its history and the phenomenon of anticipation.

Authors:  Ray M Lowenthal; Elizabeth M Tegg; Joanne L Dickinson
Journal:  Transfus Apher Sci       Date:  2013-08-19       Impact factor: 1.764

8.  Guidelines for investigating causality of sequence variants in human disease.

Authors:  D G MacArthur; T A Manolio; D P Dimmock; H L Rehm; J Shendure; G R Abecasis; D R Adams; R B Altman; S E Antonarakis; E A Ashley; J C Barrett; L G Biesecker; D F Conrad; G M Cooper; N J Cox; M J Daly; M B Gerstein; D B Goldstein; J N Hirschhorn; S M Leal; L A Pennacchio; J A Stamatoyannopoulos; S R Sunyaev; D Valle; B F Voight; W Winckler; C Gunter
Journal:  Nature       Date:  2014-04-24       Impact factor: 49.962

9.  A retrospective examination of mean relative telomere length in the Tasmanian Familial Hematological Malignancies Study.

Authors:  Nicholas B Blackburn; Jac C Charlesworth; James R Marthick; Elizabeth M Tegg; Katherine A Marsden; Velandai Srikanth; John Blangero; Ray M Lowenthal; Simon J Foote; Joanne L Dickinson
Journal:  Oncol Rep       Date:  2014-10-24       Impact factor: 3.906

10.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962
  10 in total
  4 in total

1.  Analysis of ITGB2 rare germ line variants in chronic lymphocytic leukemia.

Authors:  Grace Tiao; M Reina Improgo; Eugen Tausch; Stacey M Fernandes; Jasmin Bahlo; Sandra Robrecht; Kirsten Fischer; Michael Hallek; Stephan Stilgenbauer; Adam Kiezun; Gad Getz; Jennifer R Brown
Journal:  Blood       Date:  2017-10-19       Impact factor: 22.113

2.  Inhibitory effect of CUL1 on atherosclerosis through the p53 pathway.

Authors:  Xi Zhang; Youwei Lu; Wei Jiang; Qianhong Yang
Journal:  Ann Transl Med       Date:  2022-09

3.  Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia.

Authors:  Jie Wei; Xun-Jun Huang; Yan Huang; Ming-Yue Xiong; Xiang-You Yao; Zhi-Ning Huang; Si-Nian Li; Wei-Jie Zhou; Da-Lang Fang; Dong-Hong Deng; Peng Cheng
Journal:  Ann Transl Med       Date:  2021-09

4.  Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates CXCR4 in inherited risk.

Authors:  Julie E Feusier; Michael J Madsen; Brian J Avery; Justin A Williams; Deborah M Stephens; Boyu Hu; Afaf E G Osman; Martha J Glenn; Nicola J Camp
Journal:  J Transl Genet Genom       Date:  2021-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.